FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080426420> ?p ?o ?g. }

• W3080426420 endingPage "1074" @default.
• W3080426420 startingPage "1066" @default.
• W3080426420 abstract "BackgroundHeparin-bonded polytetrafluoroethylene grafts were marketed to improve hemodialysis access outcomes but are twice the cost of standard polytetrafluoroethylene. We launched a randomized trial of heparin-bonded polytetrafluoroethylene versus standard polytetrafluoroethylene for hemodialysis access to compare patency. Since the trial began, additional studies were published with heterogeneous findings. We performed an interim analysis by Bayesian methods using prior probability from meta-analysis of existing literature.MethodsNCT01601873 is a randomized, blinded trial of heparin-bonded polytetrafluoroethylene versus standard polytetrafluoroethylene for dialysis access at 5 sites. Planned sample size was 200 with 1-year primary patency as the primary endpoint. At interim analysis (50% of sample size at 1 year), we also performed a meta-analysis for 1-year primary patency with a random effects model to compute summary rate ratio and standard-error estimates. Meta-analysis estimates formed a prior probability for a Bayesian Cox regression model, and trial data were reanalyzed to develop posterior probability of heparin-bonded polytetrafluoroethylene effectiveness at our hypothesized effect size. Futility analysis was conducted using posterior probability estimates.ResultsOne hundred and five patients were enrolled at the time of interim analysis. One-year primary patency was 34.9% in the heparin-bonded-polytetrafluoroethylene group vs 32.7% in the standard-polytetrafluoroethylene group (P = .884). Summary rate ratio from the meta-analysis (1,209 patients) was 0.87 favoring heparin-bonded polytetrafluoroethylene (P = .33). Posterior hazard ratio from Cox regression was 0.90 (credible interval 0.70–1.13) favoring heparin-bonded polytetrafluoroethylene, which was not significant. Bayesian posterior probability of the a priori hypothesized 20% better patency with heparin-bonded polytetrafluoroethylene was 24%. Sample size to detect superiority with the small observed effect size would require about 3,800 subjects.ConclusionCurrent evidence does not demonstrate sufficiently large benefit of heparin-bonded polytetrafluoroethylene over standard polytetrafluoroethylene for dialysis access to justify higher cost. Given similar 1-year patency rates, a conclusive finding of superiority was judged to be infeasible, and the trial was stopped for futility." @default.
• W3080426420 created "2020-09-01" @default.
• W3080426420 creator A5000593874 @default.
• W3080426420 creator A5004608049 @default.
• W3080426420 creator A5011576270 @default.
• W3080426420 creator A5026281024 @default.
• W3080426420 creator A5032744186 @default.
• W3080426420 creator A5041816155 @default.
• W3080426420 creator A5063700724 @default.
• W3080426420 creator A5065071257 @default.
• W3080426420 creator A5069371561 @default.
• W3080426420 creator A5078574924 @default.
• W3080426420 date "2020-12-01" @default.
• W3080426420 modified "2023-09-25" @default.
• W3080426420 title "Heparin-bonded versus standard polytetrafluoroethylene arteriovenous grafts: A Bayesian perspective on a randomized controlled trial for comparative effectiveness" @default.
• W3080426420 cites W1689285800 @default.
• W3080426420 cites W1805640211 @default.
• W3080426420 cites W1966905436 @default.
• W3080426420 cites W1971557594 @default.
• W3080426420 cites W1997694190 @default.
• W3080426420 cites W2005972061 @default.
• W3080426420 cites W2026739428 @default.
• W3080426420 cites W2045184477 @default.
• W3080426420 cites W2046197386 @default.
• W3080426420 cites W2050302634 @default.
• W3080426420 cites W2056366475 @default.
• W3080426420 cites W2057897080 @default.
• W3080426420 cites W2059707463 @default.
• W3080426420 cites W2095674834 @default.
• W3080426420 cites W2109584203 @default.
• W3080426420 cites W2132411024 @default.
• W3080426420 cites W2144986452 @default.
• W3080426420 cites W2170302543 @default.
• W3080426420 cites W2172151487 @default.
• W3080426420 cites W2190175847 @default.
• W3080426420 cites W2201548325 @default.
• W3080426420 cites W2320350515 @default.
• W3080426420 cites W2343135772 @default.
• W3080426420 cites W2462890798 @default.
• W3080426420 cites W2468996569 @default.
• W3080426420 cites W2500374245 @default.
• W3080426420 cites W2585979311 @default.
• W3080426420 doi "https://doi.org/10.1016/j.surg.2020.07.013" @default.
• W3080426420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32859392" @default.
• W3080426420 hasPublicationYear "2020" @default.
• W3080426420 type Work @default.
• W3080426420 sameAs 3080426420 @default.
• W3080426420 citedByCount "2" @default.
• W3080426420 countsByYear W30804264202022 @default.
• W3080426420 countsByYear W30804264202023 @default.
• W3080426420 crossrefType "journal-article" @default.
• W3080426420 hasAuthorship W3080426420A5000593874 @default.
• W3080426420 hasAuthorship W3080426420A5004608049 @default.
• W3080426420 hasAuthorship W3080426420A5011576270 @default.
• W3080426420 hasAuthorship W3080426420A5026281024 @default.
• W3080426420 hasAuthorship W3080426420A5032744186 @default.
• W3080426420 hasAuthorship W3080426420A5041816155 @default.
• W3080426420 hasAuthorship W3080426420A5063700724 @default.
• W3080426420 hasAuthorship W3080426420A5065071257 @default.
• W3080426420 hasAuthorship W3080426420A5069371561 @default.
• W3080426420 hasAuthorship W3080426420A5078574924 @default.
• W3080426420 hasBestOaLocation W30804264201 @default.
• W3080426420 hasConcept C126322002 @default.
• W3080426420 hasConcept C141071460 @default.
• W3080426420 hasConcept C159985019 @default.
• W3080426420 hasConcept C168563851 @default.
• W3080426420 hasConcept C192562407 @default.
• W3080426420 hasConcept C207103383 @default.
• W3080426420 hasConcept C2777557582 @default.
• W3080426420 hasConcept C2778063415 @default.
• W3080426420 hasConcept C2780557906 @default.
• W3080426420 hasConcept C44249647 @default.
• W3080426420 hasConcept C61943457 @default.
• W3080426420 hasConcept C71924100 @default.
• W3080426420 hasConceptScore W3080426420C126322002 @default.
• W3080426420 hasConceptScore W3080426420C141071460 @default.
• W3080426420 hasConceptScore W3080426420C159985019 @default.
• W3080426420 hasConceptScore W3080426420C168563851 @default.
• W3080426420 hasConceptScore W3080426420C192562407 @default.
• W3080426420 hasConceptScore W3080426420C207103383 @default.
• W3080426420 hasConceptScore W3080426420C2777557582 @default.
• W3080426420 hasConceptScore W3080426420C2778063415 @default.
• W3080426420 hasConceptScore W3080426420C2780557906 @default.
• W3080426420 hasConceptScore W3080426420C44249647 @default.
• W3080426420 hasConceptScore W3080426420C61943457 @default.
• W3080426420 hasConceptScore W3080426420C71924100 @default.
• W3080426420 hasIssue "6" @default.
• W3080426420 hasLocation W30804264201 @default.
• W3080426420 hasOpenAccess W3080426420 @default.
• W3080426420 hasPrimaryLocation W30804264201 @default.
• W3080426420 hasRelatedWork W113810927 @default.
• W3080426420 hasRelatedWork W1977146315 @default.
• W3080426420 hasRelatedWork W2002120878 @default.
• W3080426420 hasRelatedWork W2025499134 @default.
• W3080426420 hasRelatedWork W2047967234 @default.
• W3080426420 hasRelatedWork W2087871120 @default.
• W3080426420 hasRelatedWork W2356500668 @default.
• W3080426420 hasRelatedWork W2439875401 @default.

• next